- Home
- PLX vs EP Comparison
PLX vs EP Comparison
Compare PLX & EP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- EP
- Stock Information
- Founded
- PLX 1993
- EP 1983
- Country
- PLX United States
- EP United States
- Employees
- PLX N/A
- EP N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- EP Oil & Gas Production
- Sector
- PLX Health Care
- EP Energy
- Exchange
- PLX Nasdaq
- EP Nasdaq
- Market Cap
- PLX 160.2M
- EP 162.1M
- IPO Year
- PLX 1998
- EP N/A
- Fundamental
- Price
- PLX $2.87
- EP $4.01
- Analyst Decision
- PLX Strong Buy
- EP
- Analyst Count
- PLX 1
- EP 0
- Target Price
- PLX $15.00
- EP N/A
- AVG Volume (30 Days)
- PLX 753.1K
- EP 27.1K
- Earning Date
- PLX 05-09-2025
- EP 05-14-2025
- Dividend Yield
- PLX N/A
- EP N/A
- EPS Growth
- PLX N/A
- EP N/A
- EPS
- PLX 0.04
- EP N/A
- Revenue
- PLX $53,399,000.00
- EP $44,039,178.00
- Revenue This Year
- PLX $65.02
- EP N/A
- Revenue Next Year
- PLX $57.34
- EP N/A
- P/E Ratio
- PLX $79.67
- EP N/A
- Revenue Growth
- PLX N/A
- EP 9.71
- 52 Week Low
- PLX $0.82
- EP $3.76
- 52 Week High
- PLX $3.10
- EP $8.46
- Technical
- Relative Strength Index (RSI)
- PLX 56.85
- EP 35.19
- Support Level
- PLX $2.70
- EP $3.76
- Resistance Level
- PLX $2.64
- EP $4.88
- Average True Range (ATR)
- PLX 0.17
- EP 0.39
- MACD
- PLX -0.01
- EP -0.08
- Stochastic Oscillator
- PLX 61.67
- EP 15.82
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the US onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.